期刊档案 · Medicine-Internal Medicine
Kidney Medicine
ISSN 2590-0595 · Elsevier · United States
Kidney Medicine 中科院 医学 3区（2025 年升级版），影响因子 4.1（官网公布），完全开放获取，APC 约 2,590 美元，出版商公布投稿到接收约 133 天，2025 年发文 274 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Kidney Medicine 由 Elsevier 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Dialysis and Renal Disease Management、Chronic Kidney Disease and Diabetes、Renal Diseases and Glomerulopathies 等主题的论文，这 3 个主题约占 47.1%，主导子领域为 Nephrology。（根据 OpenAlex 主题统计与中科院分区数据生成）
An Official Journal of the National Kidney FoundationKidney Medicine ®, an official journal of the National Kidney Foundation, is an open access journal focused on clinical medicine in nephrology and hypertension. The mission of Kidney Medicine is to disseminate knowledge relevant to the care of people with or at risk of kidney diseases. Articles appearing in Kidney Medicine include original research, case reports and reviews. Kidney Medicine adheres to the high standards associated with all of the National Kidney Foundation journals. Original research articles span a wide range of topics, including qualitative and quantitative research; health care policy, delivery, and disparities research; and epidemiology and outcomes research. Recognizing a critical deficit in this area, Kidney Medicine also eagerly seeks research focused on assessing and improving nephrology education and patient reported outcomes.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Medicine-Internal Medicine
主编 Mahboob Rahman出版商官网
编委会国家分布：中国大陆 1 位（约 1%）；主要国家 美国 49、加拿大 8、澳大利亚 6、印度 4、罗马尼亚 3（共 88 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Dialysis and Renal Disease ManagementMedicine23.2%
- Chronic Kidney Disease and DiabetesMedicine15.1%
- Renal Diseases and GlomerulopathiesMedicine8.8%
- Acute Kidney Injury ResearchMedicine7.7%
- Renal Transplantation Outcomes and TreatmentsMedicine5.8%
- Organ Donation and TransplantationMedicine3.4%
- Parathyroid Disorders and TreatmentsMedicine3.3%
- Central Venous Catheters and HemodialysisHealth Professions3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 泌尿学与肾脏学UROLOGY & NEPHROLOGY | 3 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 泌尿学与肾脏学UROLOGY & NEPHROLOGY | 2 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 4.1出版商官网 ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore（出版商公布）
- 4.8出版商官网 ·
- SJR 2026-06
- 1.31LetPub ·
- SNIP 2026-06
- 1.38LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 373OpenAlex ·
- 两年平均被引
- 1.96OpenAlex ·
- 自引率
- 2.4%LetPub ·
- Gold OA 文章占比
- 99.56%LetPub ·
发文规模
- 年文章数
- 202LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,522 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 312 | 312 | 66 |
| 2025 | 274 | 274 | 460 |
| 2024 | 173 | 173 | 961 |
| 2023 | 176 | 176 | 1,749 |
| 2022 | 178 | 178 | 2,285 |
| 2021 | 181 | 181 | 2,297 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
样本不足近 24 个月只有 1 篇文章登记了投稿与接收日期，不足以给出中位数
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
各来源数据
- 平均审稿速度（社区反馈）
- 12 WeeksLetPub ·
- 投稿到首次决定
- 6 天出版商官网 ·
- 外审后首次决定
- 71 天出版商官网 ·
- 投稿到接收
- 133 天出版商官网 ·
- 投稿到发表（期刊自报）
- 约 40 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 2,590 | 有 | CC BY、CC BY-NC-ND | |
| OpenAlex | USD 2,590 / EUR 2,420 / GBP 2,070 / JPY 321,240 | — | — | |
| LetPub | USD 2,400 | 有 | — | |
| 出版商官网 | USD 2,710 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点4 项，摘自作者指南
- 正文篇幅
- ≤ 3,500 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- 图文摘要
- 可选
接收的文章类型15 种，含篇幅限制
- case reportCase Reports present interesting, rare, and/or novel situations that bring to the attention of the experienced practitioner and others newly described clinical …正文 ≤ 1,500 词 · 摘要 ≤ 200 词 · 图表 ≤ 4 · 参考文献 ≤ 20
- case seriesA description of the clinical course of 11 or more actual individuals or patients with a condition of interest.未说明篇幅
- clinical trialClinical Trial Rationale & Objective Study Design Setting & Participants Intervention(s) Outcomes Results Limitations Conclusions Funding Trial Registration未说明篇幅
- decision analysis or cost-effectiveness analysisAn analysis that weighs choices in clinical care by modeling the projected consequences of different strategies to identify the optimal choice and/or to inform …未说明篇幅
- diagnostic test studyA study that compares the performance of 2 or more diagnostic tests or strategies.未说明篇幅
- editorialncerning a current issue in nephrology. Editorials are limited to 1,500 words and 1 figure, table, or box; in most cases, editorials have正文 ≤ 1,500 词 · 图表 ≤ 1 · 参考文献 ≤ 20
- editorialsAn article that provides focused commentary and narrative analysis concerning a current issue in nephrology.未说明篇幅
- letters to the editorLetters should be in response to an article in Kidney Medicine and should not exceed 250 words (up to 5 references and 1 figure or table may also be included) a…正文 ≤ 250 词 · 图表 ≤ 1 · 参考文献 ≤ 5
- observational studyCohort, Case-Control, Cross-sectional, Case-Cohort, and Ecological Studies These studies observe and describe individuals or patients based on their exposure to…未说明篇幅
- original researchOriginal Research articles may evaluate pathogenesis, consequences, and treatment of kidney disease; kidney transplantation and dialysis therapies; and disorder…未说明篇幅
- perspectiveor of argument, and clinical relevance. Perspectives are limited to 3,000 words of body text and 4 figures/tables/boxes in total; an unstru正文 ≤ 3,000 词 · 摘要 ≤ 200 词 · 图表 ≤ 4 · 参考文献 ≤ 70
- reviewAn authoritative exploration of a clinical, translational, or basic science topic of interest to practitioners. Clinically focused Reviews should describe the t…正文 ≤ 4,000 词 · 摘要 ≤ 200 词 · 参考文献 ≤ 100
- reviewsAn authoritative exploration of a clinical, translational, or basic science topic of interest to practitioners.未说明篇幅
- systematic reviewA systematic review follows an explicit protocol to systematically identify, appraise, and synthesize the findings of studies that address a similar question; a…未说明篇幅
- systematic review or meta-analysisA systematic review follows an explicit protocol to systematically identify, appraise, and synthesize the findings of studies that address a similar question; a…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、开放获取、同行评审、自存档、试验注册 / 报告规范
- AI 使用 Declaration of Generative AI in Scientific Writing
作者在写作过程中使用生成式人工智能（AI）及AI辅助技术时，只能用于提高可读性和语言表达，不得替代解释数据或得出科学结论等关键研究任务，须在人类监督和控制下使用并仔细审查和编辑结果，且不得将AI列为作者或共同作者或引用AI为作者。 模型中文摘要
Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should:Only use these technologies to improve readability and language, not to replace key researcher tasks such as interpreting data or drawing scientific conclusions.Apply the technology with human oversight and control, and carefully review and edit the result, as AI can genera…
原文 ↗出版商官网 ·- 作者资格 Authorship
按照国际医学期刊编辑委员会（ICMJE）建议，每位作者必须同时满足以下4项条件：对研究的构思与设计、数据获取或数据分析与解释作出实质性贡献；起草文章和/或对重要学术内容进行修改；批准提交稿件的最终版本；接受相关责任。 模型中文摘要
Authorship In accordance with International Committee of Medical Journal Editors (ICMJE) recommendations, each author must meet all 4 of the following conditions; moreover, each person fulfilling these conditions must be listed as an author.(1) the individual made a substantial contribution to conception and design of the study, to data acquisition, or to data analysis and interpretation; and(2) t…
原文 ↗出版商官网 ·- 利益冲突 Potential Conflicts of Interest for Authors
Kidney Medicine的利益冲突（COI）政策总体遵循ICMJE建议，作者必须披露所有可能被视为潜在COI的关系，编辑可将COI披露信息作为编辑决策的依据。 模型中文摘要
Kidney Medicine's conflict of interest (COI) policies generally follow those of the ICMJE Recommendations. As described in the Support, [Financial Disclosure](#Financial Disclosure), and [Other Disclosures](#Other Disclosures) sections of this document, authors must disclose all relationships that could be viewed as a potential COI. Editors may use information in COI disclosures as the basis for e…
原文 ↗出版商官网 ·- 数据可用性 Data Sharing
自2018年7月1日起，每篇报告临床试验的稿件应包含数据共享声明，期刊目前对数据共享没有特别期望（除要求向编辑提供数据供检查外），仅要求作者对其数据共享情况保持透明。 模型中文摘要
Data Sharing In recognition of the increased attention given to reproducibility of research findings, and to enhance opportunities for research collaboration, as of July 1, 2018, each manuscript reporting a clinical trial should include a data sharing statement. Of note, at this stage Kidney Medicine does not have a particular data sharing expectation (beyond the requirement to make data available…
原文 ↗出版商官网 ·- 出版伦理 Misconduct Handling Policy
Kidney Medicine编辑在怀疑或收到可信的违反期刊政策指控时，通常会遵循COPE建议，尽一切合理努力维护学术记录的完整性；提交给期刊的潜在不当行为报告应尽可能包含详细信息以协助编辑调查。 模型中文摘要
Misconduct Handling Policy The Kidney Medicine editors recognize their role in making all reasonable efforts to maintain the integrity of the scholarly record, and will generally follow COPE recommendations when they suspect or receive credible allegations of a breach of journal policies. Any reports of potential misconduct submitted to the journal should include as much detailed information as po…
原文 ↗出版商官网 ·- 开放获取 Open Access
Kidney Medicine是开放获取期刊，文章一经发表即永久免费供读者阅读和下载，作者或其代表（如研究资助者或机构）需支付开放获取费用（即文章出版费APC）。 模型中文摘要
Kidney Medicine is an open access journal: once published, all articles are immediately and permanently free to read and download. To provide open access, Kidney Medicine has an open access fee (also known as an article publishing charge, or APC), which needs to be paid by the authors or on their behalf, such as by their research funder or institution. We refer you to our Open Access information p…
原文 ↗出版商官网 ·- 同行评审
Kidney Medicine实行单盲审稿：审稿人可以看到作者身份，但作者无法看到审稿人身份。 模型中文摘要
Kidney Medicine conducts single-blind review: authors' identities are not masked to the reviewers, but reviewers' identities are masked to the authors.
原文 ↗出版商官网 ·- 自存档 Prepublication Embargo
Kidney Medicine不会发表已在线或以印刷形式传播的内容，若文章或其关键内容的保密性在发表前未得到维护，文章的录用可能被取消；作者机构若准备发布新闻稿，应联系编辑部了解禁发日期。 模型中文摘要
Kidney Medicine will not publish content that has already been disseminated online or in print. If the confidentiality of a Kidney Medicine article or its key elements is not maintained up to the point it is published by Kidney Medicine, the article's acceptance for publication may be forfeited. Further information is available in the Originality section of the Submission Policies.If an author's i…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
为减少发表偏倚并便于荟萃分析识别临床试验，Kidney Medicine要求涉及临床试验的稿件作者在公共试验注册机构前瞻性注册其研究；期刊将临床试验定义为任何前瞻性地将参与者分配到干预组（有或无对照组）以研究健康相关干预与健康相关结局之间因果关系的研究项目。 模型中文摘要
To help limit publication bias and to aid in the identification of clinical trials for meta-analyses, Kidney Medicine requires that authors of manuscripts pertaining to clinical trials have prospectively registered their study in a public trials registry. Kidney Medicine defines a clinical trial as any research project that prospectively assigns participants to an intervention (with or without a c…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- 出版国家或地区
- United States
- 出版语言
- English
- ISSN
- 2590-0595
- 学会 / 主办单位
- National Kidney Foundation
常见问题
关于 Kidney Medicine 的常见问题
Kidney Medicine 是中科院几区期刊？
2025 年升级版分区表中，Kidney Medicine 为医学 3区，小类 泌尿学与肾脏学 3 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。
Kidney Medicine 的影响因子是多少？
期刊官网公布的影响因子为 4.1，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 4.8，h-index 为 46。
Kidney Medicine 的审稿周期多长？
出版商公布的投稿到接收时间约为 133 天；投稿社区反馈的平均审稿速度为约 12 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Kidney Medicine 的投稿格式要求是什么？
据期刊作者指南：正文篇幅：≤ 3,500 词；参考文献格式：顺序编码制（按引用顺序编号）；首次投稿格式：允许不按期刊格式排版（free format）；图文摘要：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Kidney Medicine 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 88 位编委中，中国大陆 1 位（约 1%）；人数最多的国家是 美国（49 位）、加拿大（8 位）、澳大利亚（6 位）。统计按编委会页面列出的机构国家计，仅供参考。
Kidney Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Kidney Medicine 被 ESCI、Scopus、DOAJ 收录。
Kidney Medicine 是开放获取期刊吗？版面费多少？
Kidney Medicine 为完全开放获取。APC 约 2,590 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。